Cue Biopharma, Inc.

CUE · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$11,701$27,492$13,136$22,459
Short-Term Investments$6,971$470$0$929
Receivables$2,286$532$0$945
Inventory$0$0$0$0
Other Curr. Assets$4,861$0$1,883$0
Total Curr. Assets$25,819$30,844$15,931$25,138
Property Plant & Equip (Net)$4,909$5,572$4,112$4,841
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$153$0$153$0
Tax Assets$0$0$0$0
Other NC Assets$763$4,291$2,058$2,212
Total NC Assets$5,825$9,863$6,323$7,053
Other Assets$0$0$0$0
Total Assets$31,644$40,707$22,254$32,191
Liabilities
Payables$2,348$3,627$3,784$2,823
Short-Term Debt$3,489$2,416$3,374$4,333
Tax Payable$0$0$0$0
Deferred Revenue$7,816$0$0$0
Other Curr. Liab.$625$9,579$2,610$85
Total Curr. Liab.$15,524$19,254$15,498$13,689
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$190$190$0$0
Total NC Liab.$2,874$3,294$176$1,003
Other Liabilities$0$0$0$0
Cap. Leases$0$5,218$3,751$4,543
Total Liabilities$18,398$22,548$15,674$14,692
Equity
Pref Stock$0$0$0$0
Common Stock$78$76$62$62
Retained Earnings-$370,051-$362,603-$354,121-$341,864
AOCI$1$0$0$0
Other Equity$0-$0$0$0
Total Equity$13,246$18,159$6,580$17,499
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$31,644$40,707$22,254$32,191
Net Debt-$8,212-$25,076-$9,762-$18,126